In the interest of providing the public with sufficient time for planning and comment, TPSAC provides the information below regarding participation. The public may participate via written submissions and/or in-person, oral comments in the event that the meeting does take place.
TPSAC provides the following document for public comment:
For updates on the final meeting:
For updates on all FDA advisory committee tentative meetings:
As part of the TPSAC’s required report to the Secretary of Health and Human Services, the committee will complete their discussion of issues related to the nature and impact of the use of dissolvable tobacco products on the public health, including such use among children. Discussion will include such topics as the composition and characteristics of dissolvable tobacco products, product use, potential health effects, and marketing.
Public Participation Information
|Means of Participation||Instructions||Due Date|
|Written submissions||Please send 20 paper copies and one electronic copy addressed to the contact person below.||On or before February 17, 2012|
(Tentatively March 1, 2012, 1:30 - 2:30 p.m)
|Please submit a brief, written statement addressed to the contact person below. Please describe:
||On or before February 9, 2012|
Caryn Cohen, M.S.
Center for Tobacco Products
Food and Drug Administration
9200 Corporate Boulevard
Rockville, MD 20850
Phone: 1-877-287-1373 (choose Option 4)
DISCLAIMER: The information in these materials is not a formal dissemination of information by FDA and does not represent agency position or policy. The information is being provided to TPSAC to aid the committee in its evaluation of the issues and questions referred to the committee. The FDA will not issue a final determination on the issues at hand until input from the advisory committee process has been considered and all reviews have been finalized. The final determination may be affected by issues not discussed at the advisory committee meeting.